Vyalev Injection
Product Images NDC 0074-0501

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Vyalev (NDC 0074-0501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Foscarbidopa, An Inhibitor Of Aromatic Amino Acid Decarboxylation, Is A White To Light Yellow Powder, Freely Soluble In Aqueous Media, With A Molecular Weight Of 306.21 G/mol Anhydrous. It Is Designated Chemically As (2s)-2-hydrazinyl-3-[3-hydroxy-4-(phosphonooxy)phenyl]-2-methylpropanoic Acid Trihydrate. Its Empirical Formula Is C10h15n2o7p (anhydrous Basis), And Its Structural Formula Is: (Vyalev 01)

Chemical structure diagram of foscarbidopa, part of the foscarbidopa/foslevodopa injection product Vyalev by AbbVie Inc. The structure includes a phenol group, hydrazine, and phosphate moiety with labeled stereochemistry and hydration notation.*

FDA Label Image

Foslevodopa, An Aromatic Amino Acid, Is A White To Off-white Powder, Freely Soluble In Aqueous Media, With A Molecular Weight Of 277.17 G/mol. It Is Designated Chemically As (2s)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl] Propanoic Acid. Its Empirical Formula Is C9h12no7p, And Its Structural Formula Is: (Vyalev 02)

Chemical structure diagram of foscarbidopa, part of the active ingredients foscarbidopa/foslevodopa in Vyalev injection. The diagram shows the molecular arrangement with functional groups including hydroxyl, amine, carboxyl, and phosphate groups.*

FDA Label Image

A Graph Of A Graph Showing The Results Of A Weekdescription Automatically Generated With Medium Confidence (Vyalev 03)

A line graph comparing mean normalized time (hours) over a 12-week period between oral CD/LD and Vyalev, with sample sizes indicated below. The graph shows data points from baseline through weeks 1, 2, 3, 4, 8, and 12, featuring error bars for each data point.*

FDA Label Image

A Graph With Lines And Numbersdescription Automatically Generated With Medium Confidence (Vyalev 04)

A line graph comparing mean normalized time (hours) over multiple visits between two treatments: Oral CD/LD and VYALEF (foscarbidopa/foslevodopa injection). Data points with error bars indicate trends from baseline to week 12, with sample sizes noted for each time point.*

FDA Label Image

Figure A (Vyalev 05)

An instructional diagram showing four components related to Vyalev injection: a pre-filled syringe with measurement markings, a small vial, an injection site cap or cover, and two alcohol prep pads. The layout suggests these are parts of the subcutaneous injection preparation and administration process.*

FDA Label Image

Syringe (Vyalev 06)

An instructional diagram labeling four components commonly included in an injectable medication kit: Syringe, Solution Vial, Vial Adapter, and Alcohol Pads. Each label identifies the respective item used in preparation and administration of the injection.*

FDA Label Image

A Hand Holding A Small Bottledescription Automatically Generated (Vyalev 07)

Vyalev injection vial held in a hand, showing a clear label with the product name Vyalev. A magnified inset highlights an area on the vial label, intended for the lot number and expiration date, though the exact details are obscured in the image. The vial is for subcutaneous injection by AbbVie Inc.*

FDA Label Image

Figure C (Vyalev 08)

An instructional illustration showing three vials. The top vial has a checkmark above it, indicating it is acceptable. The bottom left and bottom right vials have 'no' symbols (circle with a diagonal line) over them, indicating they are not acceptable. The image likely guides proper vial appearance or condition for use but contains no text or branding.*

FDA Label Image

A Picture Containing Textdescription Automatically Generated (Vyalev 09)

Illustration showing a person washing their hands under a running water tap, with lathered soap on their hands. The image demonstrates proper handwashing technique as part of hygiene instructions.*

FDA Label Image

Figure E (Vyalev 0a)

An instructional illustration showing a hand gripping a vial with the thumb pulling upward on the vial's cap, suggesting removal of the cap from the vial.*

FDA Label Image

Figure F (Vyalev 0b)

An instructional illustration showing hands removing a cap or seal from a vial, likely demonstrating the preparation step for a Vyalev subcutaneous injection.*

FDA Label Image

Vial Adapter (Vyalev 0c)

FDA Label Image

Figure G (Vyalev 0d)

An instructional diagram showing hands holding a syringe with a vial cap being removed. An arrow indicates upward movement for removing the cap. A zoomed inset highlights a tab on the vial cap for easier grip, illustrating preparation steps for injection administration.*

FDA Label Image

Figure H (Vyalev 0e)

An instructional illustration showing hands preparing a subcutaneous injection using a syringe and vial. The image depicts the process of drawing medication into the syringe, associated with the Vyalev (foscarbidopa/foslevodopa) injection by AbbVie Inc.*

FDA Label Image

Figure I (Vyalev 0f)

An instructional illustration showing proper and improper techniques for attaching a vial to a syringe. The left side depicts the correct vertical alignment of the vial and syringe, while the right side shows an incorrect angled insertion. The image is intended to guide correct assembly for injection preparation.*

FDA Label Image

Figure J (Vyalev 10)

An instructional illustration showing a hand holding a syringe filled with liquid, with the plunger being pressed downward, indicating the action of expelling air or preparing the syringe for injection.*

FDA Label Image

Figure K (Vyalev 11)

An instructional illustration showing a syringe filled with liquid, with a checkmark symbol next to it, indicating a correct or approved step or condition related to an injection process.*

FDA Label Image

Figure L (Vyalev 12)

Illustration showing a syringe filled with a liquid containing bubbles and a prohibition symbol next to it, indicating that the syringe should not contain bubbles before administration.*

FDA Label Image

Figure M (Vyalev 13)

An instructional illustration shows hands holding a syringe with arrows indicating a twisting or turning motion. The image likely demonstrates a step in preparing or using a subcutaneous injection but contains no specific product branding or text.*

FDA Label Image

Figure N (Vyalev 14)

An instructional illustration depicting the preparation of a subcutaneous injection using a syringe. It shows a hand pulling back the syringe plunger to draw medication from a vial or container, indicated by arrows suggesting motion. The image visually guides on filling the syringe before administration.*

FDA Label Image

Figure O (Vyalev 15)

An instructional illustration depicting hands handling a syringe for Vyalev (foscarbidopa/foslevodopa) injection. The hands are shown pulling back the plunger to draw medication, with a magnified inset highlighting the needle attachment area on the syringe. This diagram likely demonstrates preparation for subcutaneous injection.*

FDA Label Image

Figure P (Vyalev 16)

An instructional illustration showing a hand holding a syringe filled with liquid medication. The syringe is marked with measurement lines and includes a close-up inset highlighting the measurement scale to ensure accurate dosing.*

FDA Label Image

Figure Q (Vyalev 17)

An instructional illustration showing a hand holding a syringe, drawing liquid from a vial. The image depicts the correct technique for subcutaneous injection preparation, including needle insertion into the vial and pulling back the plunger to draw medication.*

FDA Label Image

Figure R (Vyalev 18)

An instructional illustration showing hands preparing an injection syringe by attaching or securing a connected vial or container. The image focuses on the assembly process of injection components, likely related to the Vyalev foscarbidopa/foslevodopa subcutaneous injection.*

FDA Label Image

Vyafuser Pump (Vyalev 19)

FDA Label Image

Principal Display Panelndc: 0074-0501-01attention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient.vayalev™foscarbidopa Andfoslevodopainjection120 mg And 2,400 mg Per 10 mL(12 mg And 240 mg Per mL)for Subcutaneous Use7 X 10 mL Single-dose Vialsabbvie (Vyalev 1a)

Packaging label for Vyalev injection containing foscarbidopa and foslevodopa. The label indicates a strength of 120 mg and 2,400 mg per 10 mL (12 mg and 240 mg per mL) for subcutaneous use. The product is supplied in 7 single-dose vials of 10 mL each and is labeled by AbbVie Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.